Abstract Myopodin is an actin bundling protein that shuttles between nucleus and cytoplasm in response to cell stress or during differentiation. Here, we show that the myopodin sequence 58 KKRRRRARK 66 , when tagged to either enhanced green fluorescent protein (EGFP) or to enhanced cyan fluorescent protein-CapG (ECFPCapG), is able to target these proteins to the nucleolus in HeLa or HEK293T cells. By contrast, 58 KKRR 61 -ECFP-CapG accumulates in the nucleus. Mutation of 58 KKRRRRARK 66 into alanine residues blocks myopodin nuclear import and promotes formation of cytoplasmic actin filaments. A second putative nuclear localization sequence, 612 KTSKKKGKK 620 , displays much weaker activity in a heterologous context, and appears not to be functional in the full length protein. Thus myopodin nuclear translocation is dependent on a monopartite nuclear localization sequence.
Introduction
Many physiological processes like cell migration, adhesion, division and development are accompanied by cytoskeletal rearrangements, and occur by virtue of actin binding proteins [1] that reversibly organize actin monomers into filamentous structures. Within this large group of actin binding proteins, many of which are expressed simultaneously in eukaryotic cells, actin bundling proteins take up a prominent role by cross-linking filaments into tight bundles allowing cells to perform distinct functions. In recent years, there has been a noticeable trend towards research focusing on nuclear actin binding proteins.
Nucleocytoplasmic protein trafficking occurs through nuclear pore complexes embedded in the nuclear membrane, and is mediated by transport receptors called importins and exportins. These in turn recognize transport signals in their cargoes known as nuclear localization signals and nuclear export signals [2, 3] , resulting in translocation through the nuclear pore complex via interaction with nucleoporins, the basic constituents of the nuclear pore complex. Actin binding proteins such as CapG [4, 5] , plastins/fimbrins [6] , profilin [7, 8] , thymosin [9] , supervillin [10] and Flightless I [11] , among others, have been observed to shuttle between the cytoplasm and nucleus of eukaryotic cells. While it is not entirely clear in each case which role(s) these proteins perform in the nucleus, is has been shown that some of them can modulate gene transcription controlled by steroid hormone receptors [12, 13] .
Myopodin is an actin bundling protein that shuttles between nucleus and cytoplasm in a differentiation-dependent manner in muscle cells; its nuclear localization in myoblasts shifts to the cytoplasm and Z-disc as muscle cells differentiate into myotubes [14] . Myopodin is also expressed in other tissues and (cancer) cells [15, 16] where it localizes to the nucleus and cytoplasm. We identified a weak nuclear export sequence in myopodin that is able to export an otherwise nuclear protein [5] but as such little is known about myopodin key sequences that control its nuclear import. Here we show that this is regulated by a monopartite nuclear localization sequence (NLS).
Materials and methods

Reagents
Texas Red-X-phalloidin, Alexa Ò fluor Ò 488 conjugated goat antimouse IgG and Alexa Ò fluor Ò 594 conjugated goat anti-mouse IgG were from Molecular Probes (Eugene, OR). Anti-V5 antibody and HiFi Platinum Taq polymerase were purchased from Invitrogen (Merelbeke, Belgium). Anti-GFP was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal anti-B23 (Nucleophosmin/ NPM) clone EA-53, cytochalasin D and 4,6-diamidino-2-phenylindole (DAPI) were obtained from Sigma (St. Louis, USA). Restriction enzymes were from New England Biolabs (Beverly, MA). Pfu turbo polymerase and Quikchange site-directed mutagenesis kit were from Stratagene (La Jolla, CA,USA).
cDNA cloning and constructs
pcDNA3.1/V5-His-myopodin was described previously [5] . Myopodin was subcloned into the pEGFP-N1 vector (BD Biosciences) as an EcoRI/BamHI fragment. The myopodin fragment 56 M-P 432 was created by a AgeI digest and a subsequent ligation; the deletion fragment 219 M-E 758 was obtained by a SacI digest and subsequent ligation. Fusion proteins and mutants were created using partially Abbreviations: b-gal, beta-galactosidase; ECFP, enhanced cyan fluorescent protein; EGFP, enhanced green fluorescent protein; NLS, nuclear localization sequence complementary primers as described [5] . All constructs were verified by sequencing. The EGFP-b-gal construct was generously provided by Prof. Dr. M. Bollen (Division of Biochemistry, KU Leuven, Belgium). CapG in the pECFP-C1 vector (BD Biosciences Clontech) was adapted for gateway cloning [17] .
Cell culture and transfection
HEK293T cells and HeLa cells were maintained as described [18] . HeLa cells were transiently transfected using lipofectamine reagent (Invitrogen, Merelbeke, Belgium) according to the manufacturerÕs instructions. HEK293T cells, seeded on rat tail collagen-coated coverslips, were transfected using calcium phosphate. HeLa cells were incubated with 0.2 lM cytochalasin D starting at 8 h post-transfection for 16 h. Subsequently, the cells were processed for fluorescence microscopy. Quantification of nucleocytoplasmic distribution of fusion proteins was performed by scoring 100 cells (cytoplasmic only, or cytoplasmic and nuclear). Experiments were performed in triplicate. Mean values and S.D. were calculated. Axiovision 4.4 software (Zeiss, Gö ttingen) was used to calculate the ratio of nuclear fluorescence versus cytoplasmic fluorescence in transfected cells.
Fluorescence microscopy and immunocytochemistry
Staining of cells and fluorescence microscopy were performed as described [6] . Confocal microscopy was done with a LSM-510 CLSM microscope equipped with software package LSM510 version 3.2 (Zeiss) as described in more detail in [19] .
Miscellaneous
Lysis of cells and Western blot analysis were performed as described [20] . Proteins were visualized by enhanced chemiluminescence detection (ECL, Amersham Pharmacia Biotech, Buckinghamshire, UK). Protein concentrations were determined by the method of Bradford [21] using bovine serum albumin as a standard.
Results
Myopodin deletion fragments exhibit a differential
localization in cells A previous study [14] showed that two putative nuclear localization signals of myopodin, 58 KKRR 61 and 616 KKGK 619 , were not functional because mutation of two lysine residues in these sequences ( 58 AARR 61 ; 616 AAGK 619 ) did not affect the localization of the actin binding protein. Initially, we studied nuclear targeting of myopodin in various cell types using enhanced green fluorescent protein (EGFP)-tagged truncation variants of myopodin (Fig. 1A) . Full length myopodin-EGFP localized to the nucleus and cytoplasm (also onto actin stress fibers) following expression in HeLa cells, but stronger nuclear enrichment was observed in HEK293T cells (Fig. 1B) . The myopodin fragment 56 M-P 432 , tagged to EGFP, lacks the nuclear export sequence 3 P-L 24 [5] and localized to the nucleus and cytoplasm in HeLa or HEK293T cells (Fig. 1C) . Nuclear entry by passive diffusion of this fusion protein is unlikely because its molecular mass exceeds 60 kDa, which is above the limit for passive diffusion [22] . By contrast, expression of myopodin 219 M-E 758 -EGFP promoted a subcellular distribution in HeLa cells consisting of a fiber-like pattern in the cytoplasm, due to association with actin filaments (Fig. 1D, left) . No nuclear enrichment of this myopodin truncation mutant was observed in HEK293T cells either (Fig. 1D,  right) . Expression of these constructs was confirmed by Western blotting (Fig. 1E) , and quantification of data for HeLa cells is depicted in Fig. 1F . The nuclear localization of myopodin-EGFP constructs in HEK293T cells was observed in close to 100% of the cells. Full length myopodin-EGFP and myopo- Fig. 2A, bottom panel) . Because EGFP shows a strong tendency to accumulate in the nucleus through passive diffusion, the myopodin 58 KKRRRR-ARK 66 / 612 KTSKKKGKK 620 sequences were also tagged to enhanced cyan fluorescent protein (ECFP)-CapG, a 67 kDa fusion protein that is not enriched in the nucleus when the fluorescent protein is tagged to the amino terminus of CapG (Fig. 2B, left panels) . We observed nucleolar fluorescence for myopodin NLS1-ECFP-CapG in various cell types, as evidenced by co-staining with the nucleolar marker nucleophosmin (B23) (Fig. 2B) . These findings were confirmed by confocal microscopy (data not shown). By contrast, 612 KTSKKKGKK 620 (NLS2)-tagged ECFP-CapG remained entirely cytoplasmic (data not shown). As mutation of both lysine residues in the sequence 58 KKRR 61 did not affect myopodin localization [14] , we coupled all four residues 58 KKRR 61 to ECFP-CapG and compared its targeting activity to 58 KKRRRRARK 66 . Interestingly, this fusion protein exhibited strong fluorescence in the nucleus, but not in the nucleolus (Fig. 3A) . Myopodin NLS1, NLS2 or the 58 KKRR 61 sequence were also expressed as a fusion protein with EGFP-b-gal, resulting in a large tetrameric polypeptide of >500 kDa. In HeLa or HEK293T cells we noted that both myopodin NLS1 and the 58 KKRR 61 sequence strongly enhanced nuclear, but not nucleolar, accumulation of EGFP-b-gal. NLS2 was unable to target EGFP-b-gal to the nucleus (Fig. 3B) for NLS2), rather than deleting them as this could disturb the structure of myopodin more profoundly, and therefore hamper interaction with other proteins. Because myopodin shows a strong tendency to associate with actin stress fibers (see Fig. 1A ), we treated HeLa cells with 0.2 lM cytochalasin D (see Section 2). This promoted disruption of actin stress fibers (not shown) but facilitated myopodin nuclear entry, thus allowing a more balanced comparison with HEK293T cells. Expression in HeLa or HEK293T cells of a myopodin cDNA in which NLS2 was mutated (Myo NLS2Ala) did not promote a significant change in subcellular localization (Fig. 4A , compare with wild type): Myo NLS2Ala predominantly stained the nucleus in HEK293T cells, as did the wild type protein.
Similarly, wild type myopodin and Myo NLS2Ala stained the nucleus and short actin fibers in HeLa cells (Fig. 4A) . By contrast, Myo NLS1Ala no longer localized to the nucleus in HeLa or HEK293T cells, and promoted formation of extended actin filaments or actin loops in 46 ± 3.9% of HEK293T cells observed (Fig. 4B, upper panels, arrowheads) . Confocal microscopy confirmed co-localization between actin filaments and Myo NLS1Ala (data not shown). A cytoplasmic localization of this mutated protein without formation of extended actin loops was also noticed (Fig. 4B, lower panels) . Simultaneous mutation of all basic amino acids of both NLS1 and NLS2 (Myo NLS1 + 2Ala) showed a phenotype similar to Myo NLS1Ala (Fig. 4C) , and 44 ± 4.0% of HEK293T cells exhibited cytoplasmic actin loops. Mutation in myopodin of the first four basic residues of NLS1 ( 58 KKRR 61 -58 AAAA 61 ) also prevented nuclear entry of myopodin, nearly as efficiently as NLS1 (Fig. 4D) . It is not clear at present why cytoplasmic actin filaments were observed in a smaller number of cells here (10 ± 5%). Quantification of these data is shown in Fig. 5 . Taken together, our findings indicate that NLS1 is necessary and sufficient to regulate subcellular targeting of myopodin in cells, with 58 KKRR 61 representing the minimal fragment.
Conclusion
We have presented evidence that myopodin harbors a single regulatory sequence required to target the protein to the nucleus. is necessary and sufficient to prevent nuclear accumulation of myopodin. Of note, p73 [23] , a member of the p53 family of proteins, and the ubiquitin-activating enzyme [24] are also targeted to the nucleus via a KKRR sequence. However the KKRR sequence of the IL-1a propiece is required but not sufficient to localize it to the nucleus [25] . Using fluorescent reporter proteins with molecular masses ranging from small to large sizes we have demonstrated that myopodin 58 KKRRRRARK 66 targets ECFP-CapG to nucleoli whereas the shorter sequence 58 KKRR 61 translocates ECFP-CapG to nuclei. This finding is reminiscent of the NF-jB inducing kinase NIK, a protein that harbors a sequence 143 RKKRKKK 149 targeting NIK to nucleoli when nuclear export sequences of the kinase are deleted [26] . By contrast, NIK 143 AAAAKKK 149 prevents translocation into nucleoli while retaining its nuclear accumulation.
Although unexpected, it is not unprecedented that nuclear localization sequences fail to mediate nuclear/nucleolar accumulation of large carrier molecules like beta-galactosidase in contrast to small or medium size reporter proteins. Indeed, in this respect our finding that NLS1 translocates ECFP-CapG to nucleoli but not EGFP-b-gal, is similar to that reported for the NLS from angiogenin (a potent inducer of angiogenesis) [27] , HIV-Tat [28] and mouse upstream binding factor [29] .
It is difficult to gauge at present whether the myopodin nucleolar targeting sequences are physiologically relevant. However, although myopodin is a genuine dynamic shuttling protein, changing its localization during differentiation from nucleus to cytoplasm/actin fibers, but apparently absent from nucleoli, a nucleolar localization of endogenous or overexpressed myopodin can be clearly discerned in various bladder cancer cell lines [16] . Since myopodin NLS2 is able to target EGFP, but not ECFP-CapG or EGFP-b-galactosidase to nucleoli, we cannot rule out at present that this sequence may contribute to nucleolar localization of myopodin (i.e., during specific stages of differentiation or in cancer cells). This would be similar to the human ribosomal L7a protein where nucleolar targeting requires a basic domain represented by an NLS or a stretch of basic amino acids without NLS activity, in addition to another domain [30] .
Our findings are at variance with a recent report showing that deletion in myopodin of either 58 KKRR 61 or of 616 KKGKK 620 prevents its translocation to the nucleus [31] , suggesting that myopodin contains two nuclear localization sequences. However, these authors also observed that mutation of two basic residues in these sequences has no effect on myopodin localization [14] . We consider it not unlikely that deleting these sequences affects the overall structure and biological properties of myopodin more severely than mutating them. While the function of myopodin in the nucleus remains unclear at present, recent studies have shown that several (cytoplasmic) actin binding proteins are able to enter the nucleus transiently, and modulate transactivation activity of various nuclear steroid receptors (reviewed in [13] ). For instance, a-actinin2 (a bona fide actin crosslinking protein) enhances androgen receptor activity, most likely through its LXXLL motif [32] , a signature sequence typical of receptor coactivators [33] . Since myopodin also contains an LXXLL motif ( 372 LLSLL 376 ) we speculate that nuclear receptors could represent a target for nuclear myopodin. Alternatively, nuclear myopodin could modulate gene transcription by regulating the interaction between actin and RNA polymerase II. Indeed, nuclear actin is a component of the RNA polymerase II-containing preinitiation complex [34] and as such indispensable 
